Theravance Biopharma, Inc. announced that Independent Director, Bill Young, will not be standing for reelection to the Board of Directors at the company's 2023 Annual General Meeting for shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.44 USD | -6.12% | -8.46% | -24.91% |
Apr. 12 | Sector Update: Health Care Stocks Lower Friday Afternoon | MT |
Apr. 12 | Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.91% | 437M | |
+34.00% | 664B | |
+29.29% | 567B | |
-7.75% | 354B | |
+18.53% | 330B | |
+4.95% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.89% | 148B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Theravance Biopharma, Inc. Announces Independent Director, Bill Young, Will Not Be Standing for Reelection to the Board of Directors